A detailed history of Mather Group, Llc. transactions in Pfizer Inc stock. As of the latest transaction made, Mather Group, Llc. holds 24,809 shares of PFE stock, worth $681,255. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,809
Previous 50,543 50.92%
Holding current value
$681,255
Previous $1.41 Million 49.29%
% of portfolio
0.01%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$27.7 - $31.39 $712,831 - $807,790
-25,734 Reduced 50.92%
24,809 $717,000
Q2 2024

Jul 08, 2024

BUY
$25.26 - $29.6 $605,962 - $710,074
23,989 Added 90.34%
50,543 $1.41 Million
Q1 2024

Apr 08, 2024

SELL
$25.89 - $29.73 $30,524 - $35,051
-1,179 Reduced 4.25%
26,554 $736,000
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $168,172 - $218,437
-6,436 Reduced 18.84%
27,733 $798,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $284,221 - $332,226
8,857 Added 34.99%
34,169 $1.13 Million
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $380,596 - $440,341
-10,537 Reduced 29.39%
25,312 $928,000
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $641,032 - $834,530
-16,274 Reduced 31.22%
35,849 $1.46 Million
Q4 2022

Mar 10, 2023

BUY
$41.75 - $54.5 $113,100 - $147,640
2,709 Added 5.48%
52,123 $2.67 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $332,619 - $406,045
7,601 Added 18.18%
49,414 $2.16 Million
Q2 2022

Aug 16, 2022

BUY
$46.53 - $55.17 $108,787 - $128,987
2,338 Added 5.92%
41,813 $2.19 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $819,382 - $1.02 Million
17,910 Added 83.05%
39,475 $2.04 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $284,075 - $421,093
6,875 Added 46.8%
21,565 $1.27 Million
Q3 2021

Nov 04, 2021

SELL
$39.25 - $50.42 $15,150 - $19,462
-386 Reduced 2.56%
14,690 $632,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $5,853 - $6,630
163 Added 1.09%
15,076 $590,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $22,672 - $25,570
-677 Reduced 4.34%
14,913 $540,000
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $2,142 - $2,723
-64 Reduced 0.41%
15,590 $574,000
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $32,416 - $38,032
-1,021 Reduced 6.12%
15,654 $574,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $502,251 - $609,304
16,675 New
16,675 $545,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.